192 related articles for article (PubMed ID: 35669165)
1. EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma.
Chen Q; Li Y; Cheng Q; Van Valkenburgh J; Sun X; Zheng C; Zhang R; Yuan R
Onco Targets Ther; 2022; 15():597-608. PubMed ID: 35669165
[TBL] [Abstract][Full Text] [Related]
2. Predicting EGFR mutation subtypes in lung adenocarcinoma using
Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
[TBL] [Abstract][Full Text] [Related]
3. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
4. 3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma.
Liu G; Xu Z; Ge Y; Jiang B; Groen H; Vliegenthart R; Xie X
Transl Lung Cancer Res; 2020 Aug; 9(4):1212-1224. PubMed ID: 32953499
[TBL] [Abstract][Full Text] [Related]
5. Prediction of EGFR mutation status in lung adenocarcinoma based on
Tan JL; Xia L; Sun SG; Zeng H; Lu DY; Cheng XJ
Am J Nucl Med Mol Imaging; 2023; 13(5):230-244. PubMed ID: 38023818
[TBL] [Abstract][Full Text] [Related]
6.
Yang B; Ji HS; Zhou CS; Dong H; Ma L; Ge YQ; Zhu CH; Tian JH; Zhang LJ; Zhu H; Lu GM
Transl Lung Cancer Res; 2020 Jun; 9(3):563-574. PubMed ID: 32676320
[TBL] [Abstract][Full Text] [Related]
7. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK
Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433
[TBL] [Abstract][Full Text] [Related]
8. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
9. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
[No Abstract] [Full Text] [Related]
10. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
11. The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma.
Zhao W; Wu Y; Xu Y; Sun Y; Gao P; Tan M; Ma W; Li C; Jin L; Hua Y; Liu J; Li M
Front Oncol; 2019; 9():1485. PubMed ID: 31993370
[No Abstract] [Full Text] [Related]
12. Development of a Nomogram Based on 3D CT Radiomics Signature to Predict the Mutation Status of EGFR Molecular Subtypes in Lung Adenocarcinoma: A Multicenter Study.
Zhang G; Deng L; Zhang J; Cao Y; Li S; Ren J; Qian R; Peng S; Zhang X; Zhou J; Zhang Z; Kong W; Pu H
Front Oncol; 2022; 12():889293. PubMed ID: 35574401
[TBL] [Abstract][Full Text] [Related]
13. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.
Liu Y; Kim J; Balagurunathan Y; Li Q; Garcia AL; Stringfield O; Ye Z; Gillies RJ
Clin Lung Cancer; 2016 Sep; 17(5):441-448.e6. PubMed ID: 27017476
[TBL] [Abstract][Full Text] [Related]
14. Combination of
Li S; Li Y; Zhao M; Wang P; Xin J
Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
[TBL] [Abstract][Full Text] [Related]
15. Detailed identification of epidermal growth factor receptor mutations in lung adenocarcinoma: Combining radiomics with machine learning.
Li S; Luo T; Ding C; Huang Q; Guan Z; Zhang H
Med Phys; 2020 Aug; 47(8):3458-3466. PubMed ID: 32416013
[TBL] [Abstract][Full Text] [Related]
16. Dual-energy CT-based radiomics in predicting EGFR mutation status non-invasively in lung adenocarcinoma.
Ma JW; Jiang X; Wang YM; Jiang JM; Miao L; Qi LL; Zhang JX; Wen X; Li JW; Li M; Zhang L
Heliyon; 2024 Jan; 10(2):e24372. PubMed ID: 38304841
[TBL] [Abstract][Full Text] [Related]
17. Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma.
Xu F; Zhu W; Shen Y; Wang J; Xu R; Qutesh C; Song L; Gan Y; Pu C; Hu H
Front Oncol; 2020; 10():872. PubMed ID: 32850301
[No Abstract] [Full Text] [Related]
18. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.
Mei D; Luo Y; Wang Y; Gong J
Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
20. Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma.
Huo JW; Luo TY; Diao L; Lv FJ; Chen WD; Yu RZ; Li Q
Front Oncol; 2022; 12():846589. PubMed ID: 36059655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
